Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-11-06
2007-11-06
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S349100, C548S334100, C548S334500, C548S311400, C548S315100, C548S311100, C548S315400, C548S312400, C546S153000, C546S272700, C546S275100, C546S210000, C544S139000, C544S370000, C544S300000, C540S575000, C514S218000, C514S235800, C514S254050, C514S274000, C514S312000, C514S326000, C514S341000
Reexamination Certificate
active
11256573
ABSTRACT:
The present invention provides bradykinin-B1 antagonists of the formulain which A, Ar, G, Q, R1and R4are as defined in claim 1, their enantiomers, their diastereomers, their mixtures and their salts, in particular their physiologically acceptable salts with organic or inorganic acids or bases having useful properties, their preparation, medicaments comprising the pharmacologically effective compounds, their preparation and their use.
REFERENCES:
patent: 7056937 (2006-06-01), Grant et al.
patent: 7105172 (2006-09-01), Bolla
patent: WO 03/106428 (2003-12-01), None
patent: WO 2004/054584 (2004-07-01), None
patent: WO 2004/083173 (2004-09-01), None
patent: WO 2007003411 (2007-01-01), None
Conley et al. European Journal of Pharmacology 2005, 527, 44-51.
Su, Dai-Shi et al; Discovery of a potent, non-peptide bradykinin B1 receptor antagonist; Journal of the American Chemical Society; vol. 125 No. 25, pp. 7516-7517 (2003); American Chemical Society; XP002375613.
Ceci Angelo
Doods Henri
Hauel Norbert
Kauffmann-Hefner Iris
Peters Stefan
Anderson Rebecca
Boehringer Ingelheim International GmbH
Devlin Mary-Ellen M.
Morris Michael P.
Nolan Jason M
LandOfFree
Bradykinin-B1 antagonists, process for their preparation and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bradykinin-B1 antagonists, process for their preparation and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bradykinin-B1 antagonists, process for their preparation and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3862269